Literature DB >> 26617357

Endocrinologic Aspects of Hidradenitis Suppurativa.

Ioannis Karagiannidis1, Georgios Nikolakis1, Christos C Zouboulis2.   

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder of unknown etiology. The role of hormones in HS remains unclear, but the observation of premenstrual flares, female predominance, and improvement during pregnancy suggest a hormonal/metabolic background. The reported positive effects of antiandrogen therapy supports a possible role of androgens. The predominant onset of the disease years after puberty may indicate a metabolic disorder. Obesity contributes significantly to HS pathogenesis; diabetes, dyslipidemia, the metabolic syndrome, and polycystic ovarian syndrome are among the commonest comorbidities. More studies are required to clarify a potential hormonal dysregulation in HS.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acne inversa; Androgens; Apocrine glands; Endocrinology; Hidradenitis suppurativa; Hyperandrogenism; Metabolic syndrome; Obesity

Mesh:

Substances:

Year:  2016        PMID: 26617357     DOI: 10.1016/j.det.2015.08.005

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  10 in total

Review 1.  Diabetes mellitus and the skin.

Authors:  E Makrantonaki; D Jiang; A M Hossini; G Nikolakis; M Wlaschek; K Scharffetter-Kochanek; C C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 2.  The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.

Authors:  Ahmed Shah; Raed Alhusayen; Saeid Amini-Nik
Journal:  Inflamm Res       Date:  2017-06-27       Impact factor: 4.575

3.  How to Define Mild to Severe Hidradenitis Suppurativa? A Simple New Tool Based on Latent Class Analysis of EPIVER Data Study.

Authors:  Jean-Luc Perrot; François Maccari; Philippe Guillem; Anne-Claire Fougerousse; Aude Nassif; Nathalie Beneton; Elisa Cinotti; Céline Girard; Raphaelle Binois; Ziad Reguiaï
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-06-16

Review 4.  [Pathogenesis of hidradenitis suppurativa/acne inversa].

Authors:  G Nikolakis; G Kokolakis; K Kaleta; K Wolk; R Hunger; R Sabat; C C Zouboulis
Journal:  Hautarzt       Date:  2021-07-06       Impact factor: 0.751

Review 5.  [Epidemiology, patient quality of life, and treatment costs of hidradenitis suppurativa/acne inversa].

Authors:  N Kirsten; V Frings; G D Nikolakis; D Presser; M Goebeler; C C Zouboulis; M Augustin
Journal:  Hautarzt       Date:  2021-07-05       Impact factor: 0.751

6.  [Psychiatric comorbidities in hidradenitis suppurativa/acne inversa].

Authors:  Paraskevi Mavrogiorgou; Georg Juckel; Andreas Reimelt; Schapoor Hessam; Lisa Scholl; Jessica Lisa Frajkur; Eggert Stockfleth; Falk G Bechara
Journal:  Hautarzt       Date:  2021-01-04       Impact factor: 0.751

Review 7.  Skin and metabolic syndrome: A review of the possible associations.

Authors:  Neda Adibi; Reza M Robati
Journal:  J Res Med Sci       Date:  2021-02-27       Impact factor: 1.852

Review 8.  Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms.

Authors:  John W Frew; Jason E Hawkes; James G Krueger
Journal:  Ther Adv Chronic Dis       Date:  2019-03-01       Impact factor: 5.091

Review 9.  Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients.

Authors:  Ellie C Stefanadi; Georgios Dimitrakakis; Christos-Konstantinos Antoniou; Dimitrios Challoumas; Nikita Punjabi; Inetzi Aggeliki Dimitrakaki; Sangeeta Punjabi; Christodoulos I Stefanadis
Journal:  Diabetol Metab Syndr       Date:  2018-02-21       Impact factor: 3.320

10.  Anti-COVID-19 measurements for hidradenitis suppurativa patients.

Authors:  Evangelos J Giamarellos-Bourboulis; Vincenzo Bettoli; Gregor B E Jemec; Veronique Del Marmol; Angelo V Marzano; Errol P Prens; Thrasyvoulos Tzellos; Christos C Zouboulis
Journal:  Exp Dermatol       Date:  2021-06       Impact factor: 3.960

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.